Published May 17, 2021
| Version v1
Journal article
Open
Supplementary materials: endoglin in circulation is associated with favourable outcome for pemetrexed treatment in advanced non-small cell lung cancer
Creators
- 1. Divisions of Medical Oncology and Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
- 2. Divisions of Medical Oncology and Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 402, Taiwan. Institute of medicine, Chung Shan Medical University, Taichung 402, Taiwan. CSMU lung cancer research center, Chung Shan Medical University, Taichung 402, Taiwan.
- 3. Division of Dermatology, Chung Shan Medical University Hospital, Taichung 402, Taiwan. School of medicine, Chung Shan Medical University, Taichung 402, Taiwan.
- 4. Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung 40447, Taiwan.
- 5. Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 402, Taiwan.
- 6. Institute of medicine, Chung Shan Medical University, Taichung 402, Taiwan. CSMU lung cancer research center, Chung Shan Medical University, Taichung 402, Taiwan.
- 7. Divisions of Medical Oncology and Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 402, Taiwan. CSMU lung cancer research center, Chung Shan Medical University, Taichung 402, Taiwan. School of medicine, Chung Shan Medical University, Taichung 402, Taiwan.
Description
endoglin
Files
Files
(113.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:f5d7612ef5fbe2bea9d6ebb2f40c2cbe
|
113.3 kB | Download |